Source: Health Canada shortage reports · Updated Jul 29, 2026
Some Ezetimibe products are in shortage in Canada (5 of 18 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 15, 2026.
A cholesterol-lowering medication used to reduce LDL (bad) cholesterol.
Products affected
5 / 18
In shortage since
Jan 14, 2022
Est. full return
Aug 15, 2026
Reports on file
89
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
PMS-EZETIMIBE
10MG · TABLET · PHARMASCIENCE INC
DIN 02416409 · since Jul 10, 2026, est. end Aug 15, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-EZETIMIBE
10MG · TABLET · TEVA CANADA LIMITED
DIN 02354101 · since Feb 7, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
EZETIMIBE
10MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02429659 · since Jan 13, 2026, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-EZETIMIBE
10MG · TABLET · APOTEX INC
DIN 02427826 · since Dec 5, 2023, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-EZETIMIBE
10MG · TABLET · APOTEX INC
DIN 02427826 · since Jan 2, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
ACH-EZETIMIBE
10MG · TABLET · ACCORD HEALTHCARE INC
DIN 02425610 · since Jan 14, 2022, no end estimate · Disruption of the manufacture of the drug.
Anticipated
EZETIMIBE
10MG · TABLET · SANIS HEALTH INC
DIN 02431300 · Disruption of the manufacture of the drug.
Resolved
ACH-EZETIMIBE
10MG · TABLET · ACCORD HEALTHCARE INC
DIN 02425610 · ended May 8, 2026 · Requirements related to complying with good manufacturing practices.
Resolved
JAMP-EZETIMIBE
10MG · TABLET · JAMP PHARMA CORPORATION
DIN 02423235 · ended Mar 27, 2026 · Disruption of the manufacture of the drug.
Resolved
PMS-EZETIMIBE
10MG · TABLET · PHARMASCIENCE INC
DIN 02416409 · ended Dec 10, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-EZETIMIBE
10MG · TABLET · SUN PHARMA CANADA INC
DIN 02419548 · ended Oct 10, 2025 · Disruption of the manufacture of the drug.
Resolved
EZETIMIBE
10MG · TABLET · SANIS HEALTH INC
DIN 02431300 · ended Sep 22, 2025 · Disruption of the manufacture of the drug.
Showing 12 of 60 reports. All reports are on file with Health Canada.
What's happening
Ezetimibe is currently affected by 5 active shortage reports filed with Health Canada by PHARMASCIENCE INC, TEVA CANADA LIMITED, SIVEM PHARMACEUTICALS ULC, APOTEX INC and 1 others.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Ezetimibe is classified under “LIPID MODIFYING AGENTS, PLAIN” (ATC C10AX).
Recent changes
Jul 29, 2026
Estimated end date pushed back : Jul 27, 2026 → Aug 15, 2026
Jul 13, 2026
New report filed
Common questions
What is Ezetimibe used for?
A cholesterol-lowering medication used to reduce LDL (bad) cholesterol.
When will Ezetimibe be back in stock in Canada?
The latest manufacturer estimate is Aug 15, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Ezetimibe in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.